Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI · Real-Time Price · USD
22.85
-0.42 (-1.80%)
At close: Sep 2, 2026, 4:00 PM EDT
22.95
+0.10 (0.44%)
Pre-market: Sep 3, 2026, 6:03 AM EDT
Denali Therapeutics Market Cap
Denali Therapeutics has a market cap or net worth of $3.65 billion as of September 2, 2026. Its market cap has increased by 63.59% in one year.
Market Cap
3.65B
Enterprise Value
2.75B
1-Year Change
63.59%
Ranking
Category
Stock Price
$22.85
ChartMarket Cap Chart
Since December 8, 2017, Denali Therapeutics's market cap has increased from $1.89B to $3.65B, an increase of 93.54%. That is a compound annual growth rate of 7.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 3.65B | 50.84% |
| Dec 31, 2025 | 2.42B | -17.45% |
| Dec 31, 2024 | 2.93B | -1.10% |
| Dec 29, 2023 | 2.97B | -21.48% |
| Dec 30, 2022 | 3.78B | -30.66% |
| Dec 31, 2021 | 5.45B | -45.77% |
| Dec 31, 2020 | 10.04B | 500.42% |
| Dec 31, 2019 | 1.67B | -14.73% |
| Dec 31, 2018 | 1.96B | 42.57% |
| Dec 29, 2017 | 1.38B | -27.09% |
| Dec 8, 2017 | 1.89B | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veradermics | 4.11B |
| Relay Therapeutics | 4.06B |
| Viking Therapeutics | 3.91B |
| Iovance Biotherapeutics | 3.90B |
| IDEAYA Biosciences | 3.88B |
| Telix Pharmaceuticals | 3.82B |
| Arcus Biosciences | 3.80B |
| Tango Therapeutics | 3.76B |